{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:00:44Z","timestamp":1792116044105,"version":"4.4.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,27]]},"DOI":"10.1097\/tp.0b013e31815e8926","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T06:27:32Z","timestamp":1236234452000},"page":"256-263","source":"Crossref","is-referenced-by-count":33,"title":["Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts"],"prefix":"10.1097","volume":"85","author":[{"given":"Pieter","family":"Gillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Crenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Lannoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Roep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Gorus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pipeleers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Keymeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation.","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/diabetes.51.7.2148","article-title":"Successful islet transplantation: Continued insulin reserve provides long-term glycemic control.","volume":"51","author":"Ryan","year":"2002","journal-title":"Diabetes"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/00007890-200111270-00014","article-title":"Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: Analysis of incidence and risk factors.","volume":"72","author":"Maes","year":"2001","journal-title":"Transplantation"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future.","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/15256","article-title":"Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.","volume":"5","author":"Li","year":"1999","journal-title":"Nat Med"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(02)11606-0","article-title":"Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy.","volume":"360","author":"Swanson","year":"2002","journal-title":"Lancet"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.0608141103","article-title":"Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.","volume":"103","author":"Keymeulen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI119108","article-title":"Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.","volume":"98","author":"Ling","year":"15","journal-title":"J Clin Invest 1 Dec"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s001250050929","article-title":"Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.","volume":"41","author":"Keymeulen","year":"1998","journal-title":"Diabetologia"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI118950","article-title":"Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program.","volume":"98","author":"Hoorens","year":"1996","journal-title":"J Clin Invest"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diab.40.7.920","article-title":"Transplantation of purified islet cells in diabetic rats. II. Immunogenicity of allografted islet beta-cells.","volume":"40","author":"Pipeleers","year":"1991","journal-title":"Diabetes"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1432-2277.2003.tb00284.x","article-title":"Laparoscopic approach for human islet transplantation into a defined liver segment in type-1 diabetic patients.","volume":"16","author":"Movahedi","year":"2003","journal-title":"Transpl Int"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/01.RVI.0000182506.88739.39","article-title":"Feasibility, safety, and efficacy of percutaneous transhepatic injection of {beta}-cell grafts.","volume":"16","author":"Maleux","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment.","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"R16-14-20210129","first-page":"25","article-title":"Pancreatic islet and stem cell transplantation: New strategies in cell therapy of diabetes mellitus.","volume":"46","author":"Bretzel","year":"2004","journal-title":"Panminerva Med"},{"key":"R17-14-20210129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s001250100571","article-title":"Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999\u20132000). Groupe de Recherche Rhin Rhjne Alpes Geneve pour la transplantation d\u2019Ilots de Langerhans.","volume":"44","author":"Benhamou","year":"2001","journal-title":"Diabetologia"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/diacare.23.6.838","article-title":"High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.","volume":"23","author":"Decochez","year":"2000","journal-title":"Diabetes Care"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.SLA.0000072110.93780.52","article-title":"Insulin independence following isolated islet transplantation and single islet infusions.","volume":"237","author":"Markmann","year":"2003","journal-title":"Ann Surg"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.2337\/diacare.26.12.3288","article-title":"Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: The National Institutes of Health experience.","volume":"26","author":"Hirshberg","year":"2003","journal-title":"Diabetes Care"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1600-6143.2005.00957.x","article-title":"Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.","volume":"5","author":"Froud","year":"2005","journal-title":"Am J Transplant"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1600-6143.2003.00351.x","article-title":"Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody.","volume":"4","author":"Hering","year":"2004","journal-title":"Am J Transplant"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.293.7.830","article-title":"Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.","volume":"293","author":"Hering","year":"2005","journal-title":"JAMA"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.tp.0000265502.92321.ab","article-title":"The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report.","volume":"84","author":"Fung","year":"2007","journal-title":"Transplantation"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-004-1363-1","article-title":"CD40 expression on human pancreatic duct cells: Role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines.","volume":"47","author":"Vosters","year":"2004","journal-title":"Diabetologia"},{"key":"R26-14-20210129","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00125-004-1426-3","article-title":"Human pancreatic duct cells can produce tumour necrosis factor-alpha that damages neighbouring beta cells and activates dendritic cells.","volume":"47","author":"Movahedi","year":"2004","journal-title":"Diabetologia"},{"key":"R27-14-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/diabetes.48.1.29","article-title":"Contribution of ductal cells to cytokine responses by human pancreatic islets.","volume":"48","author":"Pavlovic","year":"1999","journal-title":"Diabetes"},{"key":"R28-14-20210129","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2337\/diabetes.53.6.1407","article-title":"Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation.","volume":"53","author":"Beuneu","year":"2004","journal-title":"Diabetes"},{"key":"R29-14-20210129","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1111\/j.1600-6143.2006.01512.x","article-title":"Culture medium modulates proinflammatory conditions of human pancreatic islets before transplantation.","volume":"6","author":"Marzorati","year":"2006","journal-title":"Am J Transplant"},{"key":"R30-14-20210129","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation.","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"},{"key":"R31-14-20210129","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/01.TP.0000055832.35337.E6","article-title":"Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling.","volume":"75","author":"Hu","year":"2003","journal-title":"Transplantation"},{"key":"R32-14-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.","volume":"5","author":"Pearl","year":"2005","journal-title":"Am J Transplant"},{"key":"R33-14-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-6143.2005.01195.x","article-title":"Sirolimus- associated heavy proteinuria in a renal transplant recipient: Evidence for a tubular mechanism.","volume":"6","author":"Straathof-Galema","year":"2006","journal-title":"Am J Transplant"},{"key":"R34-14-20210129","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJM200511103531922","article-title":"Post-transplantation proteinuria and sirolimus.","volume":"353","author":"Izzedine","year":"2005","journal-title":"N Engl J Med"},{"key":"R35-14-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000020648","article-title":"Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.","volume":"8","author":"Daniel","year":"2000","journal-title":"Exp Nephrol"},{"key":"R36-14-20210129","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/j.1600-6143.2005.01013.x","article-title":"Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing.","volume":"5","author":"Senior","year":"2005","journal-title":"Am J Transplant"},{"key":"R37-14-20210129","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ndt\/gfh079","article-title":"Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.","volume":"19","author":"Fervenza","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R38-14-20210129","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1600-6143.2004.00590.x","article-title":"Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction.","volume":"4","author":"Diekmann","year":"2004","journal-title":"Am J Transplant"},{"key":"R39-14-20210129","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.TP.0000056639.74982.F9","article-title":"Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.","volume":"75","author":"van Gelder","year":"2003","journal-title":"Transplantation"},{"key":"R40-14-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000088511","article-title":"Sirolimus-induced acneiform eruption.","volume":"211","author":"Kunzle","year":"2005","journal-title":"Dermatology"},{"key":"R41-14-20210129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.","volume":"43","author":"Morrisett","year":"2002","journal-title":"J Lipid Res"},{"key":"R42-14-20210129","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.ASN.0000125551.59739.2E","article-title":"Pharmacoepidemiology of anemia in kidney transplant recipients.","volume":"15","author":"Winkelmayer","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R43-14-20210129","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/01.TP.0000062837.99400.60","article-title":"Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 months.","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200801270-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:29:55Z","timestamp":1618277395000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200801270-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,27]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31815e8926","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,27]]}}}